INTRODUCTION: During the first 2 years of newborn screening (NBS) for severe combined immunodeficiency (SCID), 39 infants with an abnormal or inconclusive newborn screening test for SCID died prior to assessment of immune function. We investigated if SCID or primary T-cell lymphopenia likely contributed to the death of these neonates. METHODS: This study is a detailed retrospective chart review. RESULTS: Medical records were available in all 39 infants. Three neonates were full-term infants whose deaths were due to congenital anomalies. Thirty-three infants were born <33 weeks estimated gestational age, and the majority of these infants died from complications of prematurity. Six infants died from sepsis: two due to maternal chorioamnionitis, two due to necrotizing enterocolitis, one due to early onset group B strep sepsis, and one from a likely nosocomial infection. CONCLUSIONS: There was no evidence that SCID contributed to the cause of death in neonates with an abnormal of inconclusive NBS test for SCID.
INTRODUCTION: During the first 2 years of newborn screening (NBS) for severe combined immunodeficiency (SCID), 39 infants with an abnormal or inconclusive newborn screening test for SCID died prior to assessment of immune function. We investigated if SCID or primary T-cell lymphopenia likely contributed to the death of these neonates. METHODS: This study is a detailed retrospective chart review. RESULTS: Medical records were available in all 39 infants. Three neonates were full-term infants whose deaths were due to congenital anomalies. Thirty-three infants were born <33 weeks estimated gestational age, and the majority of these infants died from complications of prematurity. Six infants died from sepsis: two due to maternal chorioamnionitis, two due to necrotizing enterocolitis, one due to early onset group B strep sepsis, and one from a likely nosocomial infection. CONCLUSIONS: There was no evidence that SCID contributed to the cause of death in neonates with an abnormal of inconclusive NBS test for SCID.
Authors: Jaime E Hale; Francisco A Bonilla; Sung-Yun Pai; Jacalyn L Gerstel-Thompson; Luigi D Notarangelo; Roger B Eaton; Anne Marie Comeau Journal: J Allergy Clin Immunol Date: 2010-10-08 Impact factor: 10.793
Authors: M C Verschuren; I L Wolvers-Tettero; T M Breit; J Noordzij; E R van Wering; J J van Dongen Journal: J Immunol Date: 1997-02-01 Impact factor: 5.422
Authors: John M Routes; William J Grossman; James Verbsky; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Mei W Baker Journal: JAMA Date: 2009-12-09 Impact factor: 56.272
Authors: D C Douek; R A Vescio; M R Betts; J M Brenchley; B J Hill; L Zhang; J R Berenson; R H Collins; R A Koup Journal: Lancet Date: 2000-05-27 Impact factor: 79.321
Authors: Mei W Baker; William J Grossman; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Daniel F Kurtycz; Michael F Cogley; Thomas J Litsheim; Murray L Katcher; John M Routes Journal: J Allergy Clin Immunol Date: 2009-05-31 Impact factor: 10.793